Revelation Biosciences, Inc.
REVBW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $9.99K in total; no superinvestor holds it.
Other share classesREVB
Q1 2022 vs. Q4 2021
How the institutions holding Revelation Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 0 | 18 | +18 |
| Shares | 0 | 3.05M | +3.05M |
| Value | $0 | $389.0K | +$389.0K |
New holders (18)
Institutions that held Revelation Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Owl Creek Asset Management, L.P. | 985,565 | $128.0K | 0.01% |
| Linden Advisors LP | 715,752 | $86.0K | 0.00% |
| Yakira Capital Management, Inc. | 246,884 | $32.0K | 0.00% |
| Empery Asset Management, LP | 233,382 | $30.0K | 0.14% |
| Telemetry Investments, L.L.C. | 143,115 | $19.0K | 0.03% |
| Walleye Capital LLC | 107,417 | $14.0K | 0.00% |
| Polar Asset Management Partners Inc. | 98,296 | $12.0K | 0.00% |
| Capstone Investment Advisors, LLC | 91,833 | $12.0K | 0.00% |
| Jane Street Group, LLC | 75,690 | $10.0K | 0.00% |
| Ayrton Capital LLC | 75,000 | $10.0K | 0.01% |
| Wolverine Asset Management LLC | 66,273 | $8.00K | 0.00% |
| Walleye Trading LLC | 60,224 | $8.00K | 0.00% |
| Privium Fund Management B.V. | 44,000 | $6.00K | 0.00% |
| HRT Financial LP | 37,160 | $4.00K | 0.00% |
| Virtu Financial LLC | 29,935 | $4.00K | 0.00% |
| Equitec Proprietary Markets, LLC | 20,000 | $3.00K | 0.00% |
| Skaana Management L.P. | 17,815 | $2.00K | 0.00% |
| UBS Group AG | 6,419 | $1.00K | 0.00% |
Sold out (0)
Institutions that held Revelation Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
None.